How can pseudomyxoma peritonei be prevented?

How to Prevent Pseudomyxoma Peritonei

Pseudomyxoma peritonei cannot be reliably prevented through primary prevention strategies, but early detection and complete surgical removal of appendiceal mucinous neoplasms before rupture is the most critical approach to reducing risk.

Understanding the Pathophysiology

Pseudomyxoma peritonei most frequently arises from a ruptured appendiceal mucocele or mucinous epithelial neoplasm 1. The key mechanism is the spillage of mucinous cells into the peritoneal cavity, which then leads to progressive accumulation of gelatinous peritoneal metastases 2. This understanding drives prevention strategies.

Primary Prevention Strategy: Preventing Rupture

Surgical Technique During Appendectomy or Polyp Removal

The most actionable prevention strategy is meticulous surgical technique to prevent intraoperative spillage of mucinous content:

• During appendectomy for mucinous neoplasms: Avoid perforation or rupture of the appendix during manipulation and removal
• During colonoscopy with polypectomy: Exercise extreme caution when removing colonic polyps to prevent seeding neoplastic cells into the free peritoneal cavity 3
• If perforation occurs during surgery, immediate copious peritoneal lavage should be considered 4

Risk Stratification

Perforated mucinous neoplasms carry substantially higher risk:

• Perforated appendiceal mucinous neoplasms show a 65% rate of developing PMP compared to only 17% in unperforated cases 5
• Even the presence of acellular intraperitoneal mucin without frank PMP at initial surgery indicates elevated risk

Secondary Prevention: Early Detection and Surveillance

Since primary prevention is often not possible (many cases present with already-ruptured lesions), aggressive surveillance becomes the practical prevention strategy:

Who Needs Surveillance

• All patients with resected appendiceal mucinous neoplasms require systematic long-term follow-up 5
• Particularly high-risk patients:
  • Those with perforated mucinous neoplasms at initial surgery
  • Those with free intraperitoneal mucin noted at initial appendectomy
  • Those with incomplete resection margins

Surveillance Protocol

Based on current guidelines, individualized surveillance should include 1:

• CT abdomen and pelvis with IV contrast as the primary modality for detecting early peritoneal disease
• MRI abdomen and pelvis without and with IV contrast offers superior sensitivity (91% sensitivity, 95% specificity) compared to CT alone for detecting small peritoneal implants 1
• Surveillance interval: PMP can develop up to 10 years after initial appendectomy, with median time to development of 61 months (range 13-121 months) 5

Important caveat: CT has poor sensitivity for small peritoneal nodules (<0.5 cm: only 11% sensitivity), so negative imaging does not exclude early disease 1.

Tertiary Prevention: Prophylactic HIPEC

Current Evidence

The concept of prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) after resection of high-risk mucinous neoplasms has been proposed but lacks sufficient evidence for routine recommendation 5.

Key considerations:

• No randomized trials support prophylactic HIPEC
• The 2025 multisocietal consensus strongly recommends CRS plus HIPEC for established PMP, but does not address prophylactic use 6
• Given the 52% overall recurrence rate after appendectomy for mucinous neoplasms 5, prophylactic HIPEC remains an area requiring further investigation

Critical Clinical Pitfalls

1. Assuming appendiceal mucinous neoplasms are benign: PMP develops in approximately 52% of cases after resection, making this a high-risk condition requiring vigilance 5

2. Inadequate follow-up duration: PMP can manifest up to 10 years post-appendectomy; short-term surveillance is insufficient 5

3. Relying solely on CT imaging: CT significantly underestimates peritoneal disease burden, particularly for small implants. Consider MRI for higher-risk patients 1

4. Delayed referral: When PMP develops, complete cytoreductive surgery plus HIPEC was only possible in 64% of patients who developed recurrence 5. Earlier detection improves the likelihood of complete cytoreduction.

Practical Algorithm

For patients undergoing appendectomy with incidental mucinous neoplasm:

1. Intraoperatively: Document perforation status and presence of free intraperitoneal mucin
2. If perforation occurred: Consider immediate peritoneal lavage 4
3. Postoperatively: Establish long-term surveillance plan (minimum 10 years)
4. If perforated or free mucin present: Consider baseline MRI abdomen/pelvis within 6 months, then imaging every 6-12 months
5. If unperforated: Annual imaging may be sufficient, but maintain surveillance for 10 years
6. At any sign of peritoneal disease: Immediate referral to specialized center for CRS/HIPEC evaluation 6, 7